|
|
| Line 123: |
Line 123: |
| *In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. | | *In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. |
| *Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. | | *Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. |
|
| |
|
| |
|
| |
| ===2016: [https://www.lungcancerjournal.info/article/S0169-5002(16)30323-3/fulltext Patients with lung cancer: Are electronic cigarettes harmful or useful?]===
| |
| *Based on current knowledge, for patients with lung or other forms of cancer who would otherwise continue to smoke, e-cigarettes offer an alternative way to quit smoking while they undergo medical treatment. The option to switch to e-cigarettes should be considered by healthcare practitioners with patients with cancer who would otherwise continue to smoke.
| |
|
| |
|
| |
|
|
| |
|